Cardinal Capital Management

Position in BMY — Bristol Myers Squibb Co

CIK 1434845 RALEIGH, NC

Position in BMY

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$6,054,421

-$283,928 QoQ

Shares Held

105,075

+0.5% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.74%

of 13F equity value

Holder Rank

#494

of 2,506 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cardinal Capital Management holds $99,250,544 across 9 Drug Manufacturers - General names. BMY ranks #5 (6.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	26,505	$31,790,894
2	JNJ	Johnson & Johnson	114,813	$29,159,057
3	MRK	Merck & Co., Inc.	96,235	$12,366,197
4	NVS	Novartis AG	49,670	$7,784,282
5	BMY	Bristol Myers Squibb Co This page	105,075	$6,054,421
6	SNY	Sanofi	80,450	$3,431,997
7	GSK	GSK plc	62,101	$3,255,334
8	PFE	Pfizer Inc	124,537	$2,998,850

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,054,421	105,075	+0.5%	Shares	Sole	2026-07-21
2026-03-31	$6,338,349	104,507	+0.2%	Shares	Sole	2026-04-08
2025-12-31	$5,625,294	104,288	+1.0%	Shares	Sole	2026-01-30
2025-09-30	$4,654,906	103,213	+2.1%	Shares	Sole	2025-10-23
2025-06-30	$4,678,669	101,073	+3.5%	Shares	Sole	2025-07-15
2025-03-31	$5,956,222	97,659	+2.8%	Shares	Sole	2025-04-18
2024-12-31	$5,375,123	95,034	+0.4%	Shares	Sole	2025-01-31
2024-09-30	$4,898,794	94,681	+66.5%	Shares	Sole	2024-10-16
2024-03-31	$3,083,517	56,860	+12.3%	Shares	Sole	2024-07-12
2023-12-31	$2,598,851	50,650	+42.4%	Shares	Sole	2024-07-12
2023-09-30	$2,064,076	35,563	+3.1%	Shares	Sole	2024-07-12
2023-06-30	$2,205,827	34,493	—	Shares	Sole	2024-07-12
No filing history on record for this holder in this stock.